While CDKN1B/p27Kip1 loss-of-function was previously described to cause the Multiple Endocrine Neoplasia type 4 (MEN4 [77]), its role as a tumor suppressor has been demonstrated in sarcoma and lymphoma [78]. Here, CDKN1B is linked to multiple endocrine neoplasia type 4.